← Insider Monitor
BridgeBio Oncology Therapeutics, Inc. logo
BBOT

BridgeBio Oncology Therapeutics, Inc.

Nasdaq · Pharmaceutical Preparations

1
Insider trades
0
Congress trades

Company Overview

A concise company profile alongside the latest public filing activity.

BridgeBio Oncology Therapeutics develops small-molecule drugs targeting cancer-driving mutations, including RAS and SHP2 inhibitors, for patients with genetically defined tumors.

Industry
Pharmaceutical Preparations
Headquarters
South San Francisco, CA
Exchange
Nasdaq

Company profile sourced from SEC filings.

Corporate Insider Trades

Open-market purchases and sales by directors, officers, and other company insiders.

InsiderTypeValueDate
Cobo MarcPrincipal Accounting OfficerSell$185Nov 13, 2026

Source: SEC EDGAR Form 4 filings

Congressional Trades

Recent disclosures by members of the U.S. House and Senate.

No recent congressional disclosures found for BBOT.

Source: Senate eFD and House Clerk STOCK Act disclosures

Get notable BBOT activity by email

Free alerts for the insider and congressional trades worth watching.

For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.